|
STICKY:
HCV/HIV Co-Infection fact sheets
(Preview)
co-infection...http://www.hcvadvocate.org/hepatitis/coinfection.html
|
Cinnamon Girl
|
0
|
3599
|
|
|
|
|
STICKY:
New forum area - HCV/HIV Co-Infection
(closed)
(Preview)
Welcome to our new forum area dedicated to HCV/HIV co-infection. If you, your partner, or care giver are affected by this please feel welcome to introduce yourself and post here, whether you are living with an HCV/HIV co-infection, on treatment or awaiting treatment, or giving support to someone...
|
Cinnamon Girl
|
0
|
3348
|
|
|
|
Cabotegravir for HIV Prevention
(Preview)
Cabotegravir (also known as S/GSK1265744) is an investigational drug that is being studied for the treatment and prevention of HIV infection.4 Current trials are underway.https://aidsinfo.nih.gov/drugs/513/cabotegravir/0/patient
|
Tig
|
3
|
3207
|
|
|
|
|
Treatment success
(Preview)
Moving over from on treatment to post treatment board. 3 month post treatment labs on Dec 23 RNA undetected, normal liver enzyme! So thankful for those DIA drugs! Giving up cigarettes today...going to slay another dragon
|
MissusB
|
8
|
401
|
|
|
|
|
US Gvmt. suing Gilead over PrEP
(Preview)
US government sues Gilead over patent for HIV PrEP November 7, 2019 The United States government filed a patent infringement lawsuit against Gilead Sciences in federal district court, accusing the drug maker of “willfully and deliberatively” infringing on HHS patents for pre-exposure pro...
|
Tig
|
0
|
390
|
|
|
|
|
Hep b reactivation
(Preview)
Not sure if this is already a topic I had my hep c treated on the astral one trial back in 2014 halfway through the trial there was a bit of a blip and I had to have a retest which is usually because of relapse but in my case it wasn't fast forward to last week and at the hospital that now sees me,my consultant...
|
Marktq1
|
18
|
4036
|
|
|
|
|
Epclusa receives FDA approval with HCV/HIV Coinfection
(Preview)
Gilead Sciences announced the FDA approval of Epclusa for the treatment of hepatitis C genotypes 1 through 6 in patients coinfected with HIV, according to a press release. “Epclusa has already helped further simplify HCV treatment among mono-infected patients, and we are pleased that HCV/HIV c...
|
Tig
|
0
|
2613
|
|
|
|
|
Hepatitis E - HEV
(Preview)
I found an interesting article, not good, just interesting. Strange stuff! In the water? I hope they run out of Hepatitis Types before they run out of alphabet...Five French patients infected with hepatitis E strain found in rabbits In a rare finding, researchers in France discovered five cases of...
|
Tig
|
0
|
2328
|
|
|
|
|
HBV/HCV Coinfection
(
1 2
)
(Preview)
I will start this by recapping a little of what I wrote in the new member section! **************************** * Detected Approx 45 years ago * Co-infection of HCV and HBV (Of course we did not know about the C back then) * Approved for 12 weeks of Harvoni .. thank you so very much but cannot yet be treate...
|
Shadowfax
|
82
|
10393
|
|
|
|
|
Sofosbuvir/velpatasvir can be administered with most antiretrovirals
(Preview)
Sofosbuvir/velpatasvir, a forthcoming combination that effectively treats all hepatitis C virus genotypes, can be safely used with most boosted antiretrovirals for people with HIV and HCV co-infection, according to a study presented at the Conference on Retroviruses and Opportunistic Infe...
|
Cinnamon Girl
|
2
|
3592
|
|
|
|
|
Sofosbuvir plus daclatasvir for 12 weeks cures most HIV/HCV coinfected patients
(Preview)
Nearly all HIV/HCV coinfected patients treated for 12 weeks with an interferon- and ribavirin-free regimen of sofosbuvir (Sovaldi) and daclatasvir (Daklinza) achieved sustained virological response, but the cure rate fell to 76% for those treated for only 8 weeks, according to results from th...
|
Cinnamon Girl
|
1
|
3599
|
|
|
|
|
Treatment of Hepatitis C in Patients with HIV Coinfection
(Preview)
Last Updated: January 30th, 2016 Treatment of Hepatitis C in Patients with HIV Coinfection
|
wmlj1960
|
2
|
3329
|
|
|
|
|
World AIDS Day 2015
(Preview)
I want to take a moment to recognize that today, December 01, 2015, is dedicated to the 27th anniversary of the World AIDS Day. May we soon see an end to these diseases. Please remember those lost and continuing the fight... https://en.m.wikipedia.org/wiki/World_AIDS_Day#
|
Tig
|
2
|
3546
|
|
|
|
|
Harvoni and Truvada together
(Preview)
If you are taking truvada and start harvoni be careful. I started my harvoni treatment 4/2/15. I did not reach undetectable status until between weeks 8-10. Around week 13 I started having activity intolerance. I would get tachycardic, light headed, and short of breath with about 15 minutes of ligh...
|
BJP
|
0
|
3123
|
|
|
|
|
Considerations for Antiretroviral Use in Patients with Coinfections Hepatitis C (HCV)/HIV Coinfection
(Preview)
Click HERE for AIDS Info guidelines portal. This is some fairly current information (4-2015) for co-infected individuals. Personally, I found the information pertaining to co-administration of Ledipasvir / Tenofovir very informative considering I take Harvoni for Hep C / Tenofovir, Etravi...
|
wmlj1960
|
1
|
3321
|
|
|
|
|
Co-infected and starting treatment tomorrow with Viekira Pak and Ribaviran
(Preview)
as the title says I start tomorrow. Looking forward to clearing this virus from my body. but the doctor and Abbie rep say to stop taking my over the counter supplements, like my daily vitamin regimen and such. Not sure why, makes no sense to me. I thought it would help make things more tolerable. Any ide...
|
xwindowuser
|
1
|
3056
|
|
|
|
|
Results from Abbvie`s Viekira Pak study TURQUOISE -1 in HCV and HIV co-infected patients
(Preview)
Monday, February 23, 2015 - AbbVie today announced that results from part one of the Phase 2 portion of its Phase2/3 open-label study, TURQUOISE-I, in genotype 1 chronic HCV patients with HIV-1 co-infection were published online in The Journal of the American Medical Association (JAMA).Additi...
|
Cinnamon Girl
|
0
|
4971
|
|
|
|
|
Telaprevir AND HIV-coinfected patients
(Preview)
The "old" SOC's continue to benefit and hold hope for the co-infected! "Adding telaprevir to pegylated interferon and ribavirin for the treatment of acute genotype 1 hepatitis C infection in HIV-positive men reduced the duration of hepatitis C therapy by half for most patients a...
|
Tig
|
3
|
12770
|
|
|
|
|
Abbvie all-oral 3D combo works well for people with HIV/HCV coinfection
(Preview)
An all-oral regimen of 3 direct-acting antivirals plus ribavirin taken for 12 weeks led to sustained virological response in 94% of HIV positive people with mostly genotype 1a hepatitis C coinfection in the TURQUOISE-I study, according to data presented at the 54th Interscience Conference on An...
|
Cinnamon Girl
|
0
|
5620
|
|
|
|
|
Spontaneous Clearance and Liver Recover
(Preview)
Hi all Just after some advice or other people's experiences. I found out I was HCV+ in May 2013, which my body cleared over the course of the rest of the year. My last bloods in March 14 confirmed that I was undetectable and I had been for 6 months so I was effectively free from Hep C I am still getting an unc...
|
sxdan
|
5
|
7955
|
|
|
|
|
No Critical Interactions Between Ledipasvir/Sofosbuvir and Certain Key Antiretrovirals
(Preview)
From the 15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, May 19- 21, 2014, Washington, DC."Ledipasvir/sofosbuvir, a fixed-dose coformulation of two direct-acting antivirals (DAAs) for HCV infection, did not have a clinically significant impact on five fr...
|
Cinnamon Girl
|
0
|
3901
|
|
|
|
|
Even Moderate Alcohol Use Raises Fibrosis Risk for Co-infected
(Preview)
"People with HIV alone or hepatitis C virus alone were more likely to have advanced liver fibrosis if they drank more alcohol, but people coinfected with both HIV and HCV had a greater risk of advanced fibrosis even with moderate or "non-hazardous" drinking, according to a rep...
|
OldenSlow
|
0
|
4445
|
|
|
|
|
this is happening so fast
(Preview)
LM -- Edited by michele on Tuesday 15th of April 2014 10:46:56 PM
|
michele
|
0
|
3271
|
|
|
|
|
Sofosbuvir/ledipasvir produces early cure (SVR12) for 100% of HIV/HCV coinfected patients
(Preview)
Treatment for 12 weeks with a coformulation of sofosbuvir and ledipasvir led to sustained response for all HIV/HCV coinfected patients with genotype 1 hepatitis C followed for 12 weeks post-treatment, according to interim findings from the ERADICATE study presented at the 49th EASL Internatio...
|
Cinnamon Girl
|
0
|
4030
|
|
|
|
|
Phase 3 Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With HCV GT 1&4 and HIV co-inf
(Preview)
http://clinicaltrials.gov/ct2/show/record/NCT02073656?term=hepatitis+c+seattle&recr=Open&rank=8
|
maddie
|
6
|
4458
|
|
|
|
|
PAN Foundation Launches HIV/AIDS Co-Pay Assistance Program
(Preview)
Not specific to co-infection, but good news nonetheless: HIV/AIDS Co-pay Assistance
|
OldenSlow
|
2
|
3907
|
|
|
|
|
Hepatitis C Liver Decompensation Remains a Problem for Coinfected
(Preview)
"Despite receiving ART, patients coinfected with HIV and HCV had higher rates of hepatic decompensation than HCV monoinfected patients," the researchers concluded. Lo Re suggested that these findings emphasize the urgency of timely hepatitis C treatment for coinfected individua...
|
OldenSlow
|
0
|
3661
|
|
|
|
|
Good news for HIV patients with latest Hep C treatments
(Preview)
People living with both HIV and hepatitis C will be amongst those to benefit the most as the new and improved hepatitis C drugs become widely available.According to Professor Gregory Dore from the Kirby Institute, hepatitis C progresses about twice as fast in people who are also infected with HIV ma...
|
Cinnamon Girl
|
6
|
5175
|
|
|
|
|
Co-Infected HIV/HCV Minorities Least Referred
(Preview)
Most patients coinfected with hepatitis C virus and HIV were not sent for treatment of their hepatitis infection, with minorities being referred least of all, according to research presented at the 2014 Conference on Retroviruses and Opportunistic Infections.Coinfected HIV/HCV minorities r...
|
Tig
|
0
|
3748
|
|
|
|
|
HCV/HIV Drug Creation Timelines
(Preview)
From the American Chemical Society: "The progress in HCV therapy in the last three years is similar to the progress that took HIV therapy ~14 years. We are at the brink of approval for an all-oral drug combination that is dosed once daily as a single pill, has >95% efficacy, and is well tolera...
|
OldenSlow
|
2
|
3826
|
|
|
